Intravitreal delivery of oligonucleotides by sterically stabilized liposomes.

Abstract

The intravitreal injection of a phosphodiester oligonucleotide encapsulated within liposomes is a new way of delivering intact oligonucleotide to the eye in a controlled manner. This offers interesting prospects for the treatment of retinal diseases.